Cibus (NASDAQ:CBUS – Get Free Report) released its quarterly earnings data on Thursday. The company reported ($0.87) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.68) by ($0.19), Zacks reports. The firm had revenue of $1.21 million for the quarter, compared to analysts’ expectations of $1.13 million. Cibus had a negative return on equity of 28.17% and a negative net margin of 10,724.78%.
Cibus Price Performance
Shares of CBUS opened at $2.19 on Friday. Cibus has a 1-year low of $1.80 and a 1-year high of $23.18. The stock has a market cap of $57.94 million, a PE ratio of -0.10 and a beta of 2.04. The firm has a fifty day moving average price of $2.34 and a 200 day moving average price of $3.38.
Analysts Set New Price Targets
Separately, Canaccord Genuity Group decreased their price objective on shares of Cibus from $20.00 to $18.00 and set a “buy” rating for the company in a research report on Wednesday, January 22nd.
Institutional Investors Weigh In On Cibus
A hedge fund recently raised its stake in Cibus stock. Bank of America Corp DE boosted its stake in Cibus, Inc. (NASDAQ:CBUS – Free Report) by 113.4% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 35,536 shares of the company’s stock after acquiring an additional 18,885 shares during the period. Bank of America Corp DE owned about 0.13% of Cibus worth $99,000 as of its most recent SEC filing. 33.81% of the stock is owned by hedge funds and other institutional investors.
About Cibus
Cibus, Inc, a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases.
Recommended Stories
- Five stocks we like better than Cibus
- Investing In Automotive Stocks
- Berkshire Hathaway Bets on Constellation Brands—Should You?
- How to Invest in Blue Chip Stocks
- Analysts Are Upgrading These 5 Software Stocks—Should You Buy?
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- 3 ETFs Every Investor Needs to Hedge S&P 500 Volatility
Receive News & Ratings for Cibus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cibus and related companies with MarketBeat.com's FREE daily email newsletter.